Biotech Watch LLC was established September 3rd 1997 to be the premier site for biotechnology information services. BiotechWatch provides access to a continuously updated interactive database that follows such parameters as products under development, status of clinical trials, cash on hand, burn rate, and upcoming clinical milestones for over 5000 products from more than 600 biotech and medical device companies. Subscribers can use any of more than fifteen search parameters to identify companies of interest.
Valuations of most biotech companies are determined by the perceived value of their technology, the success of their clinical trials, the breadth of the clinical market being addressed, their likely competitors, the strength of the strategic partnerships they have forged, the depth of their research and clinical pipelines, and their current financing. The staff of BiotechWatch have created this database to more carefully monitor these parameters across the biotechnology sector to allow investors and industry professionals to make the most informed decisions possible.
The obvious advantage of using the BiotechWatch database to follow the biotech industry is the ability to search or sort for companies and clinical trials that have specific characteristics. The database can be used as a basic research tool to access information such as cash-on-hand, milestones, trading volume, and products under development for a specific disease or medical indication. These latter parameters provide information regarding potential competitors and/or partners in specific development areas. As the timeliness of this information is of paramount importance, the BiotechWatch staff updates all clinical trial information daily and financial information such as stock price, market cap, shares outstanding, 52 week high and low and their derivative values are updated every 5 minutes.
We have gone to every effort to make this database as intuitive, helpful, comprehensive, and timely as possible. We welcome your input and suggestions to make this the best site possible.
Alfred Mansour, Ph.D.
Dr. Alfred Mansour, a founder and CEO of Biotech Watch LLC, has extensive experience in the biotech industry. Dr. Mansour has served as President of Pharmaco Genesis Corporation, a biotechnology consulting firm, and Vice President of Biotechnology Analysis at BioDiligence Partners, Inc. which conducts technical due diligence for biopharmaceutical company management and investors. In addition to his responsibilities at Biotech Watch LLC, Dr. Mansour has been a Senior Analyst for the Brown Simpson Asset Management Fund, a New York City based $500M fund that invests in publicly traded biotechnology and Internet companies. Dr. Mansour' s career includes extensive research at the Mental Health Research Institute at The University of Michigan. During that time he shared two prestigious awards: the A.E. Bennett Award (1991) from the Society of Biological Psychiatry for his contributions to the field of psychiatry and schizophrenia, and the Discovery Award (1994) for his work in elucidating the molecular biology of endogenous opiate receptor systems in the central nervous system. Dr. Mansour has served on numerous scientific committees including the American College of Neuropsychopharmacology and the National Institute of Drug Abuse's Neuroanatomy and Neurophysiology Review Subcommittee. Dr. Mansour is a member of the American College of Neuropsychopharmacology, the New York Academy of Sciences, the American Association for the Advancement of Science, the Society for Neuroscience and Sigma Xi, the national psychology honor society. Dr. Mansour has been broadly published including publications in the distinguished journals Trends in Neuroscience, the Journal of Neuroscience, Brain Research, the Journal of Pharmacology and Experimental Therapeutics, and The Proceedings Of The National Academy of Sciences. In addition, he has published over 20 chapters in scientific/medical texts. Dr. Mansour received his B.A. cum laude from Yeshiva University in 1979 and his Ph.D. with high honors from The University of Michigan in 1984.